Baxter's Lung Expansion Device May Work Too Well

A respiratory device that Baxter inherited through its $12.5 billion Hillrom acquisition might work a little too well, a problem that prompted the company to issue an urgent medical device correction.

The Deerfield, IL-based company said that its Volara device may cause oxygen desaturation (a drop in oxygen levels) or lung tissue damage due to over-expansion of the lungs (barotrauma) in the home care environment.